CHIMERA BIOENGINEERING
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor cancers, like acute lymphoblastic leukemia and lymphoma, have shown transformative results for patients unresponsive to standard therapy. However, limited efficacy against solid tumor cancers, life... -threatening toxicities, and limited persistence are impediments to these therapies making a wider impact on cancer patients. Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, maximize efficacy and extend persistence so that CARs can lead to cures.w
CHIMERA BIOENGINEERING
Social Links:
Industry:
Bioinformatics Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.chimera.bio
Total Employee:
11+
Status:
Active
Contact:
(310)497-0736
Total Funding:
30.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GoDaddy DNS Google GStatic Google Static Content
Similar Organizations
ACT Genomics
ACT Genomics is a cancer molecular information service company teamed up with experts with multiple yearsโ experience in oncology
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Asian Fund For Cancer Research
Asian Fund For Cancer Research investment in Grant - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
Life Science Angels
Life Science Angels investment in Venture Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Series A - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Chimera Bioengineering
Kairos Ventures
Kairos Ventures investment in Seed Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
The Angels' Forum
The Angels' Forum investment in Convertible Note - Chimera Bioengineering
Key Employee Changes
Date | New article |
---|---|
2022-04-28 | Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors |
Official Site Inspections
http://www.chimera.bio
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Chimera Bioengineering" on Search Engine
Chimera Bioengineering - Crunchbase Company Profile & Funding
Details. Industries. Bioinformatics. Biotechnology. Genetics. Health Care. Diversity Spotlight (US Headquarters Only) Women Founded. Headquarters Regions San Francisco Bay โฆSee details»
Chimera Bioengineering | LinkedIn
About us. Chimera's mission is to reprogram life to end cancer, using therapies that restore dignity to patients. We do this with next generation, safer and more potent, CAR T therapeutics....See details»
Asian Fund for Cancer Research Announces Chimera โฆ
Apr 28, 2022 Chimera Bioengineering is a privately held biotechnology company located in Johnson & Johnson Innovation โ JLABS in South San Francisco, California. Find out โฆSee details»
Asian Fund for Cancer Research Announces Chimera โฆ
Apr 28, 2022 Chimera Bioengineering is a privately held biotechnology company located in Johnson & Johnson Innovation โ JLABS in South San Francisco, California. Find out โฆSee details»
Chimera Bioengineering Company Profile 2024: Valuation, โฆ
Chimera Bioengineering Overview. Update this profile. Year Founded. 2015. Status. Private. Employees. 13. Latest Deal Type. Grant. Latest Deal Amount. $500K. Investors. โฆSee details»
Chimera Bioengineering - Kairos Ventures
Company Summary. Chimera Bioengineering is a biotherapeutics company building RNA based gene regulatory systems for chimeric antigen receptor CAR-T cell therapeutics โฆSee details»
Chimera Appoints New CEO, Wins AFCR BRACE Award, and โฆ
Apr 28, 2022 SOUTH SAN FRANCISCO, Calif., April 28, 2022 โ Chimera Bioengineering (โChimeraโ) a biotherapeutics company building next-generation CAR-T therapeutics โฆSee details»
Grant - Chimera Bioengineering - 2022-04-28 - Crunchbase
Summary. Overview. Organization Name. Chimera Bioengineering. Announced Date Apr 28, 2022. Funding Type Grant. Money Raised. $7.5M. Lead Investors. Asian Fund For โฆSee details»
Chimera Appoints New CEO, Wins AFCR BRACE Award, and โฆ
Apr 28, 2022 Chimera Bioengineering is a privately held biotechnology company located in Johnson & Johnson Innovation โ JLABS in South San Francisco, California. Find out โฆSee details»
Chimera Bioengineering - Funding, Financials, Valuation & Investors
Chimera Bioengineering has raised a total of. $30.7M. in funding over 6 rounds. Their latest funding was raised on Apr 28, 2022 from a Grant round. Chimera Bioengineering is โฆSee details»
Announce the 2021 BRACE Award Venture Competition Winner
Apr 28, 2022 HONG KONG โ Chimera Bioengineering has been selected as the winner of the Asian Fund for Cancer Researchโs (AFCR) 2021 BRACE Award Venture โฆSee details»
Chimera Bioengineering | CipherBio
Chimera's mission is to reprogram life to end cancer, using therapies that restore dignity to patients. We do this with next generation, safer and more potent, CAR T therapeutics. โฆSee details»
Chimera Bioengineering | Golden
Chimera Bioengineering is a biotechnology company developing cell therapies to treat cancer.See details»
Ben Wang | Chimera Bioengineering
Follow Ben on LinkedIn. Dr. Ben Wang is co-founder and COO of Chimera Bioengineering. Prior to his role at Chimera, he was co-founder at Svaya Nanotechnologies, which โฆSee details»
Chimera Bioengineering - Contacts, Employees, Board Members, โฆ
Organization. Chimera Bioengineering. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 6. โฆSee details»
Vlad Hogenhuis | Chimera Bio
Vlad Hogenhuis, MD, is President and CEO of Chimera Bioengineering and brings more than 28 years of experience in oncology, immunology, and specialty pharma. Prior to โฆSee details»
Benjamin Wang - Co-Founder @ Chimera Bioengineering
Benjamin Wang. Summary. Overview. Number of Current Board & Advisor Roles 1. Number of Founded Organizations 2. Primary Job Title Co-Founder. Primary Organization. โฆSee details»
UT BIOME: pioneering innovation at the intersection of biomedical ...
5 days ago Through their visionary guidance, the organization has embarked on a journey of groundbreaking projects and initiatives, pushing the boundaries of โฆSee details»
Updates | Chimera Bio
Jan 11, 2021 Posts. Apr 28, 2022. 4 min. Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic. Jan 11, 2021. 3 min. Why do we do โฆSee details»
Chimera Bioengineering - Crunchbase
Chimera Bioengineering, Encoded Therapeutics, Kytopen, METiS Therapeutics, HelixNano, and Pathway Genomics are part of the biotechnology and gene therapy โฆSee details»